Volume 12, Issue 4 (12-2024)                   JoMMID 2024, 12(4): 292-298 | Back to browse issues page

Ethics code: REF. NO. 78/IEC/ACPMMC/Dhule Date 28/03/2023

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Wadile R, Karuna R A, Vasave R. Prevalence and Changing Virulence Factors and Biofilm Formation among Non-Albicans Candida Species in Suspected Vulvovaginitis Infections. JoMMID 2024; 12 (4) :292-298
URL: http://jommid.pasteur.ac.ir/article-1-572-en.html
Prevalence and Changing Virulence Factors and Biofilm Formation among Non-Albicans Candida Species in Suspected Vulvovaginitis Infections
Rahul Wadile * , Ahire Karuna R , Ravidas Vasave
Department of Microbiology, Government Medical College, Nandurbar, Maharashtra, India
Abstract:   (224 Views)
Introduction: Vulvovaginal candidiasis (VVC), a common gynecological condition predominantly attributed to Candida albicans, frequently affects pregnant women. Non-albicans Candida species (NACs) are increasingly recognized as important etiological agents, potentially contributing to adverse pregnancy outcomes such as preterm birth and miscarriage. This study aimed to determine the prevalence of NACs and characterize their virulence factor profiles, including biofilm formation, in women with suspected vulvovaginitis, with the goal of informing and optimizing clinical management strategies for this condition. Methods: Cervicovaginal swabs were prospectively collected from pregnant women presenting with clinical signs and symptoms suggestive of vulvovaginitis. Identification of Candida species was performed using standard mycological techniques, encompassing microscopic examination, germ tube testing, and carbohydrate assimilation tests. The assessment of virulence factor production included biofilm formation, and the enzymatic activities of hemolysin, phospholipase, lipase, and protease (evaluated via agar diffusion assays). Statistical analyses were conducted using SPSS software (version 25.0). Results: Among the 370 cervicovaginal swabs collected from women presenting with suspected vulvovaginitis, Candida species were identified in 123 swabs (33.24%). C. albicans constituted 53.66% of the isolates, while NACs accounted for the remaining 46.34%. Within the NACs isolates, Candida tropicalis (49.12%) and Candida glabrata (28.07%) were the predominant species. Diabetes mellitus was the most common risk factor identified in women with Candida infection. Hemolysin production was the most frequently detected virulence factor among the NACs isolates, observed in 40.9% of these isolates. Conclusion: This study demonstrates the significant prevalence of NACs in vulvovaginal candidiasis cases, concurrent with the notable presence of diverse virulence factors. Our findings underscore the importance of routine mycological investigations for accurate species identification and suggest that virulence factor profiling may be critical for informing effective management strategies for VVC, particularly given the observed prevalence and potential pathogenic implications of the diverse array of virulence factors among NACs.
Keywords: Non-albicans Candida, Vulvovaginal candidiasis, Virulence factors, Biofilm, Fungal identification, Pregnant women
Full-Text [PDF 716 kb]   (60 Downloads)    
Type of Study: Original article | Subject: Infectious diseases and public health
Received: 2023/07/30 | Accepted: 2024/12/21 | Published: 2025/03/1
References
1. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev 2010; 23 (2): 253-73. [DOI:10.1128/CMR.00076-09] [PMID] [PMCID]
2. Ying C, Zhang H, Tang Z, Chen H, Gao J, Yue C, et al. Antifungal susceptibility and molecular typing of 115 Candida albicans isolates obtained from vulvovaginal candidiasis
3. patients in 3 Shanghai maternity hospitals. Med Mycol. 2016; 54 (4): 394-9. [DOI:10.1093/mmy/myv082] [PMID]
4. Foxman B, Marsh JV, Gillespie B, Sobel JD. Frequency and Response to Vaginal Symptoms among White and African American Women: Results of a Random Digit Dialing Survey. J Womens Health. 1998; 7 (9): 1167-74. [DOI:10.1089/jwh.1998.7.1167] [PMID]
5. Sobel JD. Vaginitis. N Engl J Med. 1997; 337 (26): 1896-1903. [DOI:10.1056/NEJM199712253372607] [PMID]
6. Kennedy MA, Sobel JD. Vulvovaginal Candidiasis Caused by Non-Albicans Candida Species: New Insights. Curr Infect Dis Rep. 2010; 12 (6): 465-70. [DOI:10.1007/s11908-010-0137-9] [PMID]
7. Shi XY, Yang YP, Zhang Y, Li W, Wang JD, Huang WM, et al. Molecular identification and antifungal susceptibility of 186 Candida isolates from vulvovaginal candidiasis in Southern China. J Med Microbiol. 2015; 64 (4): 390 3. [DOI:10.1099/jmm.0.000024] [PMID]
8. Segal E, Soroka A, Schechter A. Correlative relationship between adherence of Candida albicans to human vaginal epithelial cells in vitro and candidal vaginitis. Sabouraudia. 1984; 22 (3): 191-200. [DOI:10.1080/00362178485380321] [PMID]
9. Kalaiarasan K, Singh R, Chaturvedula L. Fungal profile of Vulvovaginal Candidiasis in a tertiary care hospital. J Clin Diagn Res. 2017; 11 (3): DC06-DC09. [DOI:10.7860/JCDR/2017/23578.9475] [PMID] [PMCID]
10. Mølgaard-Nielsen D, Svanström H, Melbye M, Hviid A, Pasternak B. Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth. JAMA. 2016; 315 (1): 58-67. [DOI:10.1001/jama.2015.17844] [PMID]
11. Mohandas V, Ballal M. Distribution of Candida species in different clinical samples and their virulence: Biofilm formation, proteinase and phospholipase production: A study on hospitalized patients in Southern India. J Glob Infect Dis. 2011; 3 (1): 4 8. [DOI:10.4103/0974-777X.77288] [PMID] [PMCID]
12. Luo G, Samaranayake LP, Yau JY. Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol. 2001; 39: 2971 4. [DOI:10.1128/JCM.39.8.2971-2974.2001] [PMID] [PMCID]
13. Vijaya D, Dhanalakshmi TA, Kulkarni S. Changing trends of vulvovaginal candidiasis. J Lab Physicians. 2014; 6: 28 30. [DOI:10.4103/0974-2727.129087] [PMID] [PMCID]
14. Nadeem SG, Hakim ST, Kazmi SU. Use of CHROM agar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited setting. Libyan J Med. 2010; 5: 1-6. [DOI:10.3402/ljm.v5i0.2144] [PMID] [PMCID]
15. Shin JH, Kee SJ, Shin MG, Kim SH, Shin DH, Lee SK, et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: Comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol. 2002; 40: 1244-8. [DOI:10.1128/JCM.40.4.1244-1248.2002] [PMID] [PMCID]
16. Price MF, Cawson RA. Phospholipase activity in Candida albicans. Sabouraudia. 1977; 15 (2): 179-185. [DOI:10.1080/00362177785190271]
17. Holdcroft AM, Ireland DJ, Payne MS. The vaginal microbiome in health and disease-what role do common intimate hygiene practices play? Microorganisms. 2023; 11 (2): 298. [DOI:10.3390/microorganisms11020298] [PMID] [PMCID]
18. Roy M, Majumdar T, Ray J. Vulvovaginal candidiasis in pregnant women attending a tertiary care centre in North-Eastern India. Indian J Med Microbiol. 2024; 52: 100738. [DOI:10.1016/j.ijmmb.2024.100738] [PMID]
19. MacAlpine J, Lionakis MS. Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis. Cell Host Microbe. 2024; 32 (10): 1654-1667. [DOI:10.1016/j.chom.2024.08.018] [PMID]
20. Majumdar T, Mullick JB, Bir R, Roy J, Sil SK. Determination of Virulence Factors and Biofilm Formation Among Isolates of Vulvovaginal Candidiasis. J Med Sci. 2016; 36 (2): 53-8. [DOI:10.4103/1011-4564.181521]
21. Malak NI, Khan N, Baradkar V, Jayanthi S. Characterisation of Candida in Vulvovaginitis Patients with Special Reference to Non-albicans from a Tertiary Care Hospital in Mumbai, India. NJLM. 2024; 10 (2): M19-M22.
22. Chaudhary P, Singla A, Mamoria VP, Mittal S, Bacchani D. Prevalence of Non-albicans Candida and its Antifungal Susceptibility at a Tertiary Care Hospital, Jaipur. Int J Contemp Med Res. 2020; 7 (7): G7-G10. [DOI:10.21276/ijcmr.2020.7.7.27]
23. Deorukhkar SC, Saini S, Mathew S. Non albicans Candida Infection: An Emerging Threat. Interdiscip Perspect Infect Dis. 2014; 615958. [DOI:10.1155/2014/615958] [PMID] [PMCID]
24. Jahan N, Vishnoi P, Gupta B, Srivastava S, Ahmad S, Khatoon R. Identification of various Candida species isolated from patients with vulvovaginal candidiasis attending a tertiary care hospital in North India. Int J Adv Med. 2020; 7 (2): 261-6. [DOI:10.18203/2349-3933.ijam20200076]
25. Balaraman L, Saritha N, Raveendran G. Characterization of non albicans Candida species and the antifungal susceptibility profile of clinical isolates. Indian J Microbiol Res. 2018; 5 (3): 295-8. [DOI:10.18231/2394-5478.2018.0062]
26. Pfaller MA, Diekema DJ. Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol. 2004; 42 (10): 4419-31. [DOI:10.1128/JCM.42.10.4419-4431.2004] [PMID] [PMCID]
27. Krasowska A, Sigler K. How microorganisms use hydrophobicity and what does this mean for human needs? Front Cell Infect Microbiol. 2014; 4: 112. [DOI:10.3389/fcimb.2014.00112] [PMID] [PMCID]
28. Nikawa H, Egusa H, Makihira S, Nishimura M, Ishida K, Furukawa M, et al. A novel technique to evaluate the adhesion of Candida species to gingival epithelial cells. Mycoses. 2003; 46 (9-10): 384 9. [DOI:10.1046/j.0933-7407.2003.00912.x] [PMID]
29. Fichtenbaum CJ, Aberg JA. Candidiasis and HIV. HIV InSite Knowledge Base Chapter. 2006 [cited 2015 Oct 2]. Available from: http://www.arv.ucsf.edu/InSite?page=kb-00&doc=kb-05-02-03.
30. Kvaal C, Lachke SA, Srikantha T, Daniels K, McCoy J, Soll DR. Misexpression of the opaque phase specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect Immun. 1999; 67 (12): 6652-62. [DOI:10.1128/IAI.67.12.6652-6662.1999] [PMID] [PMCID]
31. Rodrigues AG, Pina Vaz C, Costa de Oliveira S, Tavares C. Expression of plasma coagulase among pathogenic Candida species. J Clin Microbiol. 2003; 41 (12): 5792-3. [DOI:10.1128/JCM.41.12.5792-5793.2003] [PMID] [PMCID]
32. Seneviratne CJ, Jin L, Samaranayake LP. Biofilm lifestyle of Candida: A mini review. Oral Dis. 2008; 14 (7): 582-90. [DOI:10.1111/j.1601-0825.2007.01424.x] [PMID]
33. Al Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: Chemical composition and role in drug resistance. J Med Microbiol. 2006; 55 (8): 999 1008. [DOI:10.1099/jmm.0.46569-0] [PMID]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.